Baillie Gifford acquired 3.63 Million BeiGene Ltd shares worth $671 Million. That's 0.55% of their equity portfolio (35th largest holding). The investor owns 3.32% of the outstanding BeiGene Ltd stock. The first BeiGene Ltd trade was made in Q1 2016. Since then Baillie Gifford bought shares twenty more times and sold shares on sixteen occasions. The investor's estimated purchase price is $877 Million, resulting in a loss of 24%.